Matthew Ingham: Clinical Trials

1 trial sponsored by Matthew Ingham, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Withdrawn 1

Follow Matthew Ingham: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma
Selinexor, Ixazomib - Liposarcoma, Malignant Peripheral Nerve Sheath Tumors
Phase 1WithdrawnMatthew Ingham2020-11-012020-11-27

Conditions studied

Liposarcoma (1)  ·  Neurofibrosarcoma (1)  ·  Sarcoma (1)  ·  Sarcoma, Alveolar Soft Part (1)  ·  Sarcoma, Ewing (1)

Interventions

ixazomib (1)  ·  selinexor (1)

Countries

United States (1)